Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
7.83%Debt to Assets Ratio
VS
Market
Sector
Industry
History
$ 5.78Close
$ 4.28 - $ 12.48 52-Week Range
Ticker Information
Ticker
VIRCompany Name
VIR BIOTECHNOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQVIR BIOTECHNOLOGY INC - Debt to Assets Ratio Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
VIR - Debt to Assets Historical data
| Date | Total Assets | Total Debt | Debt to Assets Ratio |
|---|---|---|---|
| 6/30/2025 | $ 1.19B | $ 93.41M | 7.83% |
| 3/31/2025 | $ 1.31B | $ 88.17M | 6.74% |
| 12/31/2024 | $ 1.4B | $ 90.14M | 6.44% |
| 9/30/2024 | $ 1.5B | $ 93.41M | 6.23% |
| 6/30/2024 | $ 1.67B | $ 95.02M | 5.69% |
| 3/31/2024 | $ 1.79B | $ 109.17M | 6.09% |
| 12/31/2023 | $ 1.92B | $ 111.67M | 5.82% |
| 9/30/2023 | $ 2.04B | $ 114.12M | 5.58% |
| 6/30/2023 | $ 2.24B | $ 117.81M | 5.25% |
| 3/31/2023 | $ 2.67B | $ 121.46M | 4.56% |
Key Performance Insights, Last 5 Years
- VIR BIOTECHNOLOGY INC's latest trailing twelve months (TTM) Debt to Assets stands at 1.28%.
- Over the past 5 years, VIR BIOTECHNOLOGY INC's average Debt to Assets has been 5.62%.
- The median Debt to Assets for VIR BIOTECHNOLOGY INC during this period was 5.76%
- VIR BIOTECHNOLOGY INC reached its highest Debt to Assets over the past 5 years at 7.83%.
- The lowest Debt to Assets recorded by VIR BIOTECHNOLOGY INC in the same timeframe 1.28%
VIR BIOTECHNOLOGY INC's Debt to Assets vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt to Assets Benchmarks
Similar metrics to Debt to Assets:
- Debt to Equity Ratio - [Calculation] Debt to Equity (D/E) measures the ratio between a company’s [Liabilities] and [Equity]. A high ratio might indicate more risk.
- Cash to Assets Ratio - [Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Inventory to Assets Ratio - [Calculation] [Inventory] as percentage of total [Assets], serves as an efficiency ratio - the lower the better.
- Gross Profits to Assets - [Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].
Definition of Debt to Assets Ratio
[Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.Debt / Assets
(=) Debt to Assets Debt to Assets for VIR BIOTECHNOLOGY INC is calculated as follows: Debt [ $ 12.09M ] / Assets [ $ 943.26M ]
(=) Debt to Assets [ 1.28% ] VIR - Debt to Assets Ratio, Last 5 years
1.28%
Minimum
Sep 30, 2020
7.83%
Maximum
Jun 30, 2025
5.62%
Average
5.76%
Median
Debt to Assets Benchmark AnalysisMarket
The chart above depicts the distribution of Debt to Assets for companies in the Total Stock Market. The average Debt to Assets of the companies is 26.32% with a standard deviation of 24.51%.
The following table provides additional summary stats:
Debt to Assets in the Market:
| filtered constituents | 4.38K |
|---|---|
| min | 0% |
| max | 116.6% |
| average | 26.32% |
| median | 21.04% |
| std | 24.51% |